Visual Capitalist August 11, 2024
Freny Fernandes

Over the past few decades, the cost of insulin in the United States skyrocketed, affecting millions of people with diabetes relying on it every day.

Insulin is produced by three major manufacturers in the U.S.—Eli Lilly, Novo Nordisk, and Sanofi.

This infographic by Pernia Jamshed and Shabeeb Hammad focuses on the drastic price rise of Eli Lilly’s rapid-acting insulin, Humalog, using data sourced from Pharmaceutical Technology, NBC News, and Eli Lilly.

Cost of Insulin from 2004 to 2024

Humalog is one of the most well-known insulin brands globally. It is a fast-acting insulin that controls blood sugar levels in people with type 1 and type 2 diabetes.

In 1996, when it was first introduced, a 10 mL vial of Humalog...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
How Americans feel about weight-loss drugs, in 3 charts
Drugmakers prep for bird flu outbreak, despite continued low risk
Heart health differences in men and women: Tiny RNA molecules play key role, study finds
Advancing Cancer Care: The Role of Radiopharmaceuticals in Precision Medicine
STAT+: Nobel laureates call on National Academies and biotech CEOs to speak out against Trump attacks on science

Share This Article